Smith and Nephew forms joint venture
Smith and Nephew, the medical technology business, has agreed to form a joint venture with Essex Woodlands, a specialist healthcare growth equity and venture capital firm, to further develop its Biologics and Clinical Therapies division. The new entity, called Bioventus, will be 51% owned by Essex Woodlands and 49% by Smith & Nephew.
Smith and Nephew, the medical technology business, has agreed to form a joint venture with Essex Woodlands, a specialist healthcare growth equity and venture capital firm, to further develop its Biologics and Clinical Therapies division. The new entity, called Bioventus, will be 51% owned by Essex Woodlands and 49% by Smith & Nephew.
More to follow ...
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
-
-
Savers will benefit from Plum’s 4.94% money market account
Savers will benefit from Plum's 4.94% product that relies on money market funds that closely track the Bank of England’s base rate. We explain why this could be good news for savers.
By Rupert Hargreaves Published
-
Revealed: Best funds for DIY investors
Wondering where to put your money? With thousands of investment options, which funds, ETFs, trusts are the best? Bestinvest has just released it’s best funds list - we have all the details to help you strengthen your portfolio
By Kalpana Fitzpatrick Last updated